Home|Journals|Articles by Year|Audio Abstracts

Research Article

Open Vet J. 2023; 13(9): 1124-1134

Evaluation of factors influencing survival time in 77 dogs with lymphoma

Soo-Yeon Jeong.

Cited by 0 Articles

Back ground: Canine lymphoma is one of the most commonly reported hematopoietic tumors.

Aim: A few retrospective studies have involved complex evaluations including diagnostic features and treatment protocols, but these studies infrequently demonstrate variable factors that affect survival time, and comparisons among chemotherapeutic protocols are limited. The aim of this study was to identify prognostic factors that can be simply detected in dogs with lymphoma, such as abnormalities in physical and hematologic findings, and treatment protocols.

Methods: Clinical records of 77 dogs diagnosed with lymphoma were retrospectively reviewed.

Results: The author newly identified leukocyte and platelet abnormalities as negative prognostic factors. Furthermore, this study suggests that decreased gastrointestinal toxicity and improvements of hematologic abnormalities, such as anemia, thrombocytopenia, and lymphocytosis or lymphoblasts in peripheral blood during chemotherapy act as positive prognostic factors. Finally, strict adherence to therapeutic protocol and selecting multiple agents as rescue protocol are important to prolong survival time.

Conclusion: This study identified indicators to be used as prognostic factors through survival analysis.

Key words: dog, chemotherapy, lymphoma, prognostic factor, survival analysis.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.